Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 2 trial

2012373 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet Oncology

Volume 13, Issue 9, pp. 897-905

Field-Weighted Citation Impact: 24.57